Australia markets closed

Little Green Pharma Ltd (LGP.XA)

Cboe AU - Cboe AU Real-time price. Currency in AUD
Add to watchlist
0.1000-0.0025 (-2.44%)
At close: 01:24PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.25
52-week change 3-41.18%
S&P500 52-week change 322.55%
52-week high 30.2050
52-week low 30.0950
50-day moving average 30.1217
200-day moving average 30.1370

Share statistics

Avg vol (3-month) 375.22k
Avg vol (10-day) 3110.23k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8161.72M
% held by insiders 132.25%
% held by institutions 111.04%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -31.81%
Operating margin (ttm)-44.88%

Management effectiveness

Return on assets (ttm)-5.20%
Return on equity (ttm)-10.22%

Income statement

Revenue (ttm)25.63M
Revenue per share (ttm)0.09
Quarterly revenue growth (yoy)22.30%
Gross profit (ttm)N/A
EBITDA -5.02M
Net income avi to common (ttm)-8.15M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.97M
Total cash per share (mrq)0.02
Total debt (mrq)5.14M
Total debt/equity (mrq)6.66%
Current ratio (mrq)3.34
Book value per share (mrq)0.26

Cash flow statement

Operating cash flow (ttm)66.79k
Levered free cash flow (ttm)245.6k